136 related articles for article (PubMed ID: 227822)
1. Misonidazole-a drug for trial in radiotherapy and oncology.
Dische S; Saunders MI; Flockhart IR; Lee ME; Anderson P
Int J Radiat Oncol Biol Phys; 1979 Jun; 5(6):851-60. PubMed ID: 227822
[No Abstract] [Full Text] [Related]
2. Initial United States clinical and pharmacologic evaluation of misonidazole (Ro-07-0582), an hypoxic cell radiosensitizer.
Wasserman TH; Phillips TL; Johnson RJ; Gomer CJ; Lawrence GA; Sadee W; Marques RA; Levin VA; VanRaalte G
Int J Radiat Oncol Biol Phys; 1979 Jun; 5(6):775-86. PubMed ID: 227821
[No Abstract] [Full Text] [Related]
3. [Clinical experiences with the radiation-sensitizing agent misonidazole].
Kogelnik HD; Szepesi T; Kärcher KH; Seitz W
Strahlentherapie Sonderb; 1978; 75():115-9. PubMed ID: 162327
[No Abstract] [Full Text] [Related]
4. Final report on the United States Phase I Clinical Trial of the hypoxic cell radiosensitizer, misonidazole (Ro-07-0582; NSC #261037).
Phillips TL; Wasserman TH; Johnson RJ; Levin VA; VanRaalte G
Cancer; 1981 Oct; 48(8):1697-704. PubMed ID: 6269723
[TBL] [Abstract][Full Text] [Related]
5. Clinical experience with misonidazole: high dose fractions versus daily low doses.
Kogelnik HD
Cancer Clin Trials; 1980; 3(2):179-86. PubMed ID: 6253098
[TBL] [Abstract][Full Text] [Related]
6. I.V. misonidazole (NSC 261037). Report of initial clinical experience.
Schwade JG; Strong JM; Gangji D
Cancer Clin Trials; 1981; 4(1):33-9. PubMed ID: 7214660
[No Abstract] [Full Text] [Related]
7. Radiation Therapy Oncology Group clinical trials with misonidazole.
Wasserman TH; Stetz J; Phillips TL
Cancer; 1981 May; 47(10):2382-90. PubMed ID: 7023642
[TBL] [Abstract][Full Text] [Related]
8. Misonidazole combined with radiotherapy in the treatment of inoperable squamous cell carcinoma of the lung. A double-blind randomized trial.
Panduro J; Kjaer M; Wolff-Jensen J; Hansen HH
Cancer; 1983 Jul; 52(1):20-4. PubMed ID: 6303553
[TBL] [Abstract][Full Text] [Related]
9. The neurotoxicity of misonidazole: potential modifying role of phenytoin sodium and dexamethasone.
Wasserman TH; Phillips TL; Van Raalte G; Urtasun R; Partington J; Koziol D; Schwade JG; Gangji D; Strong JM
Br J Radiol; 1980 Feb; 53(626):172-3. PubMed ID: 6245744
[No Abstract] [Full Text] [Related]
10. Dose-response curves for predicting misonidazole-induced peripheral neuropathy.
Schwade JG; Makuch RW; Strong JM; Glatstein E
Cancer Treat Rep; 1982 Sep; 66(9):1743-50. PubMed ID: 6288238
[TBL] [Abstract][Full Text] [Related]
11. Kinetic aspects of misonidazole and its major metabolite in radiotherapy.
Meering PG; Gonzalez DG; Maes RA; van Peperzeel HA
Hum Toxicol; 1985 Jul; 4(4):425-34. PubMed ID: 4018823
[TBL] [Abstract][Full Text] [Related]
12. Misonidazole dose and tumor level relationships. Effects of individual variation in rate of misonidazole metabolism and absorption from the gastrointestinal tract.
Strong JM; Schwade JG; Gangji D; Shoemaker DD; Upton DK
Cancer Clin Trials; 1981; 4(1):41-6. PubMed ID: 7214661
[No Abstract] [Full Text] [Related]
13. [Clinical experience with daily doses of misonidazole (author's transl)].
Kogelnik HD; Reinartz G; Szepesi T; Seitz W; Wurst F; Mamoli B; Wessely P; Stark H
Strahlentherapie; 1980 Nov; 156(11):758-64. PubMed ID: 7434385
[TBL] [Abstract][Full Text] [Related]
14. [Clinical studies of combined therapy of radiation and local injection of misonidazole].
Hong SS; Abe Y; Isobe Y; Yamakawa M; Kaneta K; Kawaguchi T; Matsuzawa T; Umegaki Y
Nihon Igaku Hoshasen Gakkai Zasshi; 1983 May; 43(5):675-84. PubMed ID: 6622246
[No Abstract] [Full Text] [Related]
15. A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery; preliminary results of an RTOG study.
Nelson DF; Schoenfeld D; Weinstein AS; Nelson JS; Wasserman T; Goodman RL; Carabell S
Int J Radiat Oncol Biol Phys; 1983 Aug; 9(8):1143-51. PubMed ID: 6347995
[TBL] [Abstract][Full Text] [Related]
16. The optimum regime for the administration of misonidazole and the establishment of multi-centre clinical trials.
Dische S; Saunders MI; Flockhart IR
Br J Cancer Suppl; 1978 Jun; 3():318-21. PubMed ID: 209811
[TBL] [Abstract][Full Text] [Related]
17. [Clinical evaluation of hypoxic cell sensitizer (Misonidazole)].
Asakawa H; Watarai J; Hoshino T
Gan To Kagaku Ryoho; 1984 Jun; 11(6):1225-30. PubMed ID: 6732250
[TBL] [Abstract][Full Text] [Related]
18. The neurotoxicity of misonidazole: pooling of data from five centres.
Disch S; Saunders MI; Anderson P; Urtasun RC; Karcher KH; Kogelnik HD; Bleehen N; Phillips TL; Wasserman TH
Br J Radiol; 1978 Dec; 51(612):1023-4. PubMed ID: 216455
[No Abstract] [Full Text] [Related]
19. A comparison of the tumour concentrations obtainable with misonidazole and Ro 03-8799.
Dische S; Saunders MI; Bennett MH; Dunphy EP; Des Rochers C; Stratford MR; Minchinton AI; Wardman P
Br J Radiol; 1986 Sep; 59(705):911-7. PubMed ID: 3756388
[TBL] [Abstract][Full Text] [Related]
20. Plasma concentration of misonidazole and peripheral neuropathy.
Marten TR
Am J Clin Oncol; 1982 Apr; 5(2):239-40. PubMed ID: 6283876
[No Abstract] [Full Text] [Related]
[Next] [New Search]
